These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2832605)

  • 1. Synthesis and pharmacological activity of angiotensin converting enzyme inhibitors: N-(mercaptoacyl)-4-substituted-(S)-prolines.
    Smith EM; Swiss GF; Neustadt BR; Gold EH; Sommer JA; Brown AD; Chiu PJ; Moran R; Sybertz EJ; Baum T
    J Med Chem; 1988 Apr; 31(4):875-85. PubMed ID: 2832605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme inhibitors as antihypertensive agents: 1-[(2-mercaptocycloalkyl)carbonyl]-L-prolines.
    Ciabatti R; Padova G; Bellasio E; Tarzia G; Depaoli A; Battaglia F; Cellentani M; Barone D; Baldoli E
    J Med Chem; 1986 Mar; 29(3):411-7. PubMed ID: 3005576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the importance of spacial and conformational domains in captopril analogs for angiotensin converting enzyme activity.
    Hanessian S; Reinhold U; Saulnier M; Claridge S
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2123-8. PubMed ID: 9873498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive agents: angiotensin converting enzyme inhibitors. 1-[3-(Acylthio)-3-aroylpropionyl]-L-prolines.
    McEvoy FJ; Lai FM; Albright JD
    J Med Chem; 1983 Mar; 26(3):381-93. PubMed ID: 6298428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme.
    Seymour AA; Swerdel JN; Abboa-Offei B
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):456-65. PubMed ID: 1711608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antienzymic activity of two new angiotensin converting enzyme inhibitors.
    Dudkiewicz J; Suska T; Tautt J; Paruszewski R
    Pol J Pharmacol Pharm; 1991; 43(1):33-8. PubMed ID: 1663247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of alpha,beta-unsaturated carbonyl compounds as potential ACE inhibitors.
    Park Choo HY; Peak KH; Park J; Kim DH; Chung HS
    Eur J Med Chem; 2000 Jun; 35(6):643-8. PubMed ID: 10906415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel antihypertensive hexa- and heptapeptides with ACE-inhibiting properties: from the in vitro ACE assay to the spontaneously hypertensive rat.
    Ruiz-Giménez P; Marcos JF; Torregrosa G; Lahoz A; Fernández-Musoles R; Valles S; Alborch E; Manzanares P; Salom JB
    Peptides; 2011 Jul; 32(7):1431-8. PubMed ID: 21605609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines.
    Krapcho J; Turk C; Cushman DW; Powell JR; DeForrest JM; Spitzmiller ER; Karanewsky DS; Duggan M; Rovnyak G; Schwartz J
    J Med Chem; 1988 Jun; 31(6):1148-60. PubMed ID: 2836590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors. New orally active antihypertensive (mercaptoalkanoyl)- and [(acylthio)alkanoyl]glycine derivatives.
    Suh JT; Skiles JW; Williams BE; Youssefyeh RD; Jones H; Loev B; Neiss ES; Schwab A; Mann WS; Khandwala A
    J Med Chem; 1985 Jan; 28(1):57-66. PubMed ID: 2981324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and enzymatic evaluation of novel partially fluorinated thiol dual ACE/NEP inhibitors.
    Olimpieri F; Tambaro S; Fustero S; Lazzari P; Sanchez-Roselló M; Pani L; Volonterio A; Zanda M
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4715-9. PubMed ID: 19596577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
    Fink CA; Carlson JE; McTaggart PA; Qiao Y; Webb R; Chatelain R; Jeng AY; Trapani AJ
    J Med Chem; 1996 Aug; 39(16):3158-68. PubMed ID: 8759637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of N-(phosphonoacetyl)-dipeptide derivatives and evaluation of their antihypertensive activity.
    Osapay G; Körmöczy P; Szilágyi I; Kajtár J; Kiss B
    Pharmazie; 1990 Sep; 45(9):666-8. PubMed ID: 2178265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11.
    Fink CA; Qiao Y; Berry CJ; Sakane Y; Ghai RD; Trapani AJ
    J Med Chem; 1995 Dec; 38(26):5023-30. PubMed ID: 8544178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L -proline a novel orally active inhibitor of ACE.
    Karanewsky DS; Badia MC; Cushman DW; DeForrest JM; Dejneka T; Loots MJ; Perri MG; Petrillo EW; Powell JR
    J Med Chem; 1988 Jan; 31(1):204-12. PubMed ID: 3336020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis and Evaluation of Novel 2-Hydroxypyrrolobenzodiazepine-5,11-dione Analogues as Potent Angiotensin Converting Enzyme (ACE) Inhibitors.
    Sun Y; Bai Y; He X; Bai Y; Liu P; Zhao Z; Chen X; Zheng X
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29099799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney.
    Hiwada K; Inoue Y; Kokubu T
    Gen Pharmacol; 1990; 21(4):555-8. PubMed ID: 2165961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
    Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
    J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.